Trince
Jan Van Hauwermeiren is an accomplished business development professional with extensive experience in various leadership roles across multiple organizations. Currently serving as Vice President of Business Development at Trince since October 2023 and Managing Director at AstroLinus since September 2021, Jan previously held positions such as Business Development Director at RheaVita BV and Sales & Business Development at MOLECUBES NV. Additional experience includes roles in sales and marketing, project management, and consulting at prestigious companies such as Ovizio and SYSMEX. Jan holds a Master's degree in Biomedical Sciences from Ghent University and a Master's degree in General Management from Vlerick Business School, complemented by executive education at INSEAD.
This person is not in any teams
Trince
Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane. It can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product. www.trincebio.com